Nuanced Insights on Statin Therapy

Thomas and Peter discuss the nuances of statin therapy, emphasizing that statins are not inherently bad but should be used thoughtfully. They explore the impact of LDL and particle lowering, the role of Ezetimibe, and address concerns about cognitive impairment. This conversation sheds light on the complexity of lipid therapy and highlights the importance of individualized approaches.